title: What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies?
authors: Istituto Dermopatico dell'Immacolata, Rome, Italy. r.corona@idi.it
authors: Rosamaria
authors: R
authors: Corona
authors: Michael
authors: M
authors: Bigby